Kara Fitzgerald

Institute for Molecular Medicine — United States

Medicine · Health Sciences

9h-index516citations28works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(5), Epigenetics and DNA Methylation(5), Diet and metabolism studies(5), SARS-CoV-2 and COVID-19 Research(3), Birth, Development, and Health(3)

Publications28 total

Dietary polyphenol assessment for aging research
Aging·2025· 2 citedOpen Access
Dietary associations with reduced epigenetic age: a secondary data analysis of the methylation diet and lifestyle study
Aging·2025· 7 citedOpen Access
Correction: Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial
Aging·2024Open Access
Potential reversal of biological age in women following an 8-week methylation-supportive diet and lifestyle program: a case series
Aging·2023· 37 citedOpen Access
Reduction of biological age following an 8-week methylation-supportive diet and lifestyle program: A case series
2023· 1 citedOpen Access
The Everyday Younger You Eating Plan
Integrative and Complementary Therapies·2022
Biological Age and Functional Medicine: A Clinical Conversation with Kara Fitzgerald, ND, IFMCP, and Robert Rountree, MD
Integrative and Complementary Therapies·2022
Correction for: Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial
Aging·2022· 6 citedOpen Access
Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial
Aging·2021· 331 citedOpen Access
Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension
The Permanente Journal·2020· 23 citedOpen Access
Reversal of Epigenetic Age with Diet and Lifestyle in a Pilot Randomized Clinical Trial
2020· 3 citedOpen Access
Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?
mSphere·2020· 23 citedOpen Access
Could Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?
Preprints.org·2020· 4 citedOpen Access
Furin Protease: From SARS CoV‐2 to Anthrax, Diabetes and Hypertension
SSRN Electronic Journal·2020Open Access
Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.
PubMed·2020· 18 citedOpen Access
Large intramuscular lipoma of the tongue
Radiology Case Reports·2018· 13 citedOpen Access
Sixteen-year-old Female With Acute Abdominal Pain: A Case Report.
PubMed·2015Open Access
Significance of Low Plasma Homocysteine
2015
i Engaging User Testing
Journal of Nursing Care Quality·2015· 8 cited
56-year-old female with type 2 diabetes mellitus
Journal of Obesity and Metabolic Research·2015Open Access
page 1 of 2Next →

Frequent Co-authors

Romilly Hodges(8), Ryan Bradley(6), Mark Hyman(6), Douglas Hanes(4), Emily Stack(4), David Cheishvili(4), Moshe Szyf(4), Janine Henkel(4), Melissa W. Twedt(4), Despina Giannopoulou(4), Josette Herdell(4), Sally Logan(4), Kathie Madonna Swift(3), Tish Campbell(2), Suzanne C. Makarem(2), Stephen W. Mamber(2), Steven Krakowka(2), Jeffrey L. Osborn(2), Lloyd Saberski(2), Neal Wright(2)